J Chlumský

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

Noel G. McElvaney, Jonathan Burdon, Mark Holmes et al. · The Lancet Respiratory Medicine · 2016 · 191 citations · Full text

Open-label Extension Trial, Long-term Efficacy, Immunology +2

Chronic Obstructive Pulmonary Disease: Official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care

Vladimír Koblížek, J Chlumský, Vladimir Zindr et al. · Biomedical Papers · 2013 · 145 citations · Full text

Strategy Aimed at Reduction of Sputum Eosinophils Decreases Exacerbation Rate in Patients with Asthma

J Chlumský, M. Teřl, Jan Vondráček · Journal of International Medical Research · 2006 · 96 citations

Asthma, Pulmonary Care, Allergy +11

Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting

Gert‐Jan Braunstahl, J Chlumský, Guy Peachey et al. · Allergy Asthma and Clinical Immunology · 2013 · 68 citations · Full text

Diagnosis and management of α₁-antitrypsin deficiency in Europe: an expert survey

Ildikó Horváth, Maria Canotilho, J Chlumský et al. · ERJ Open Research · 2019 · 48 citations · Full text